One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
The gut microbiota and diabetes: research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach
Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden
Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults
Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans
Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans
The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity
Non-invasive quantification of stem cell-derived islet graft size and composition
Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study
Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men
HbA1c variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes
Spatial proteomics of human diabetic kidney disease, from health to class III
The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes
Correction: Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women
Correction: Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults
